Bionomics News

Buy Rating Affirmed for Bionomics' BNC210 Following Promising PTSD Study Results

TipRanksMar 27 12:45 ET

Bionomics's BNC210 Shows Promise for PTSD Treatment: A Buy Rating Analysis

TipRanksMar 21 12:05 ET

Bionomics Analyst Ratings

BenzingaMar 21 12:01 ET

HC Wainwright & Co. Reiterates Buy on Bionomics, Maintains $8 Price Target

BenzingaDec 7, 2023 06:38 ET

Bionomics Analyst Ratings

BenzingaDec 7, 2023 06:37 ET

Promising Progress of BNC210 Bolsters Buy Rating on Bionomics Amidst Rising Interest in SAD Treatments

TipRanksOct 3, 2023 06:17 ET

Positive Phase 2b Study Results Bolster Buy Rating for Bionomics' PTSD Drug BNC210

TipRanksSep 28, 2023 12:45 ET

Maxim Group Maintains Buy on Bionomics, Raises Price Target to $10

BenzingaSep 28, 2023 12:43 ET

HC Wainwright & Co. Upgrades Bionomics to Buy, Announces $8 Price Target

BenzingaSep 28, 2023 12:33 ET

Bionomics Analyst Ratings

BenzingaSep 28, 2023 12:28 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Travere Therapeutics (TVTX) and Bionomics (BNOX)

TipRanksAug 7, 2023 12:10 ET

H.C. Wainwright Keeps Their Hold Rating on Bionomics (BNOX)

TipRanksMar 9, 2023 12:17 ET

Loops Capital Adjusts Price Target on Bionomics to $17 From $10, Keeps Buy Rating

MT NewswiresMar 9, 2023 10:31 ET

Tesla To $285? Here Are 10 Other Price Target Changes For Tuesday

Benzinga Real-time NewsDec 20, 2022 08:08 ET

Bionomics Analyst Ratings

Benzinga Analyst RatingsDec 20, 2022 05:07 ET

Evercore ISI Group Downgrades Bionomics to In-Line, Lowers Price Target to $6

Benzinga Real-time NewsDec 20, 2022 05:07 ET

Bionomics Analyst Ratings

Benzinga Analyst RatingsDec 19, 2022 06:12 ET

Bionomics Analyst Ratings

Benzinga Analyst RatingsNov 1, 2022 09:05 ET

Loop Capital Initiates Coverage On Bionomics With Buy Rating, Announces Price Target of $23

Benzinga Real-time NewsNov 1, 2022 09:04 ET

H.C. Wainwright Reaffirms Their Buy Rating on Bionomics (BNOX)

TipRanksJul 27, 2022 09:30 ET